Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Thornburg Investment Management Inc.

Thornburg Investment Management Inc. lowered its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 9.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 105,989 shares of the company’s stock after selling 10,536 shares during the period. Thornburg Investment Management Inc.’s holdings in Ryan Specialty were worth $6,800,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Barclays PLC lifted its position in Ryan Specialty by 1.1% during the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock worth $108,994,000 after acquiring an additional 17,267 shares during the period. Embree Financial Group raised its stake in shares of Ryan Specialty by 64.1% during the fourth quarter. Embree Financial Group now owns 83,212 shares of the company’s stock worth $5,339,000 after purchasing an additional 32,500 shares during the last quarter. KBC Group NV lifted its holdings in shares of Ryan Specialty by 1,803.6% during the fourth quarter. KBC Group NV now owns 46,181 shares of the company’s stock worth $2,963,000 after purchasing an additional 43,755 shares during the period. Mutual of America Capital Management LLC grew its position in Ryan Specialty by 1.7% in the 4th quarter. Mutual of America Capital Management LLC now owns 56,203 shares of the company’s stock valued at $3,606,000 after buying an additional 914 shares during the last quarter. Finally, Truist Financial Corp grew its position in Ryan Specialty by 7.2% in the 4th quarter. Truist Financial Corp now owns 5,688 shares of the company’s stock valued at $365,000 after buying an additional 381 shares during the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Stock Performance

NYSE RYAN opened at $70.67 on Friday. The business has a 50 day moving average price of $70.16 and a 200 day moving average price of $68.73. The company has a market capitalization of $18.55 billion, a P/E ratio of 102.42, a PEG ratio of 1.19 and a beta of 0.68. Ryan Specialty Holdings, Inc. has a 1-year low of $52.34 and a 1-year high of $77.16. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, meeting the consensus estimate of $0.39. The company had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. Ryan Specialty’s revenue was up 25.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.35 earnings per share. Sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a $0.48 annualized dividend and a yield of 0.68%. Ryan Specialty’s dividend payout ratio (DPR) is currently 141.18%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on RYAN. Barclays reduced their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an “overweight” rating for the company in a research note on Friday, April 11th. Royal Bank of Canada lowered their price objective on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a report on Friday, February 21st. UBS Group boosted their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Keefe, Bruyette & Woods reduced their price target on Ryan Specialty from $76.00 to $75.00 and set an “outperform” rating for the company in a report on Wednesday, April 9th. Finally, TD Cowen began coverage on Ryan Specialty in a research note on Thursday, April 10th. They issued a “buy” rating and a $89.00 price target on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $76.42.

Insiders Place Their Bets

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the business’s stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is currently owned by company insiders.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.